INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "7H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS USEFUL FOR THE TREATMENT OF CANCER"

GENEVA, Jan. 5 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/056453) for "7H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS USEFUL FOR THE TREATMENT OF CANCER" on Jun 25, 2025. With publication no. WO/2026/003749, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRINER, Karin (65 Prince StreetCambridge, Massachusetts 02139), CHEN, Xin (Novartis Institutes for Biomedical Research, Inc.250 Massachusetts AvenueCambridge, Massachusetts 02139), GAO, Xiang (Novartis...